Repository logo
 
Publication

Molecular detection of multiple antimicrobial resistance genes in helicobacter pylori-positive gastric samples from patients undergoing upper gastrointestinal endoscopy with gastric biopsy in Algarve, Portugal

dc.contributor.authorNunes, Francisco José Viegas Cortez
dc.contributor.authorAguieiras, Catarina
dc.contributor.authorCalhindro, Mauro
dc.contributor.authorLouro, Ricardo
dc.contributor.authorPeixe, Bruno
dc.contributor.authorQueirós, Patrícia
dc.contributor.authorCastelo-Branco, Pedro
dc.contributor.authorMateus, Teresa Letra
dc.date.accessioned2025-09-23T09:00:56Z
dc.date.available2025-09-23T09:00:56Z
dc.date.issued2025-08-01
dc.description.abstractBackground/Objectives: Helicobacter pylori (H. pylori) is a common gastric pathogen linked to gastritis, gastroduodenal ulcers, and gastric cancer. Rising antimicrobial resistance (AMR) poses challenges for effective treatment and has prompted the WHO to classify H. pylori as a high-priority pathogen. This study aimed to detect the prevalence of AMR genes in H. pylori-positive gastric samples from patients in Algarve, Portugal, where regional data is scarce. Methods: Eighteen H. pylori-positive gastric biopsy samples from patients undergoing upper gastrointestinal endoscopy were analyzed. PCR and sequencing were used to identify genes associated with resistance to amoxicillin (Pbp1A), metronidazole (rdxA, frxA), tetracycline (16S rRNA mutation) and clarithromycin (23S rRNA). Sequence identity and homologies were verified using tBLASTx and the Comprehensive Antibiotic Resistance Database (CARD). Results: Out of the 18 H. pylori-positive samples, 16 (88.9%) contained at least one AMR gene. The most frequent genes were rdxA (83.3%) and frxA (66.7%) for metronidazole resistance, and the 16S rRNA mutation (66.7%) for tetracycline. Resistance to amoxicillin and clarithromycin was detected in 27.8% and 16.7% of cases, respectively. Most samples (72.2%) had multiple resistance genes. A significantly strong association was found between female sex and the presence of the rdxA gene (p = 0.043). Conclusions: The study reveals a high prevalence of H. pylori resistance genes in Algarve, particularly against metronidazole and tetracycline. These findings highlight the need for local surveillance and tailored treatment strategies. Further research with larger populations is warranted to assess regional resistance patterns and improve eradication efforts.eng
dc.identifier.doi10.3390/antibiotics14080780
dc.identifier.issn2079-6382
dc.identifier.urihttp://hdl.handle.net/10400.1/27724
dc.language.isoeng
dc.peerreviewedyes
dc.publisherMDPI
dc.relationCenter for Research and Development in Agrifood Systems and Sustainability
dc.relationCenter for Research and Development in Agrifood Systems and Sustainability
dc.relation.ispartofAntibiotics
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectMetronidazole
dc.subjectTetracycline
dc.subjectPCR
dc.subjectSequencing
dc.subjectAMR
dc.titleMolecular detection of multiple antimicrobial resistance genes in helicobacter pylori-positive gastric samples from patients undergoing upper gastrointestinal endoscopy with gastric biopsy in Algarve, Portugaleng
dc.typejournal article
dspace.entity.typePublication
oaire.awardTitleCenter for Research and Development in Agrifood Systems and Sustainability
oaire.awardTitleCenter for Research and Development in Agrifood Systems and Sustainability
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F05937%2F2020/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F05937%2F2020/PT
oaire.citation.issue8
oaire.citation.startPage780
oaire.citation.titleAntibiotics
oaire.citation.volume14
oaire.fundingStream6817 - DCRRNI ID
oaire.fundingStream6817 - DCRRNI ID
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
person.familyNameNunes
person.familyNameQueirós
person.familyNameCastelo-Branco
person.givenNameFrancisco José Viegas Cortez
person.givenNamePatrícia
person.givenNamePedro
person.identifier.ciencia-idE015-7F8F-5CA1
person.identifier.orcid0000-0001-6638-9782
person.identifier.orcid0000-0003-3575-426X
person.identifier.orcid0000-0002-3453-3978
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
relation.isAuthorOfPublicationaf03f692-441f-4403-964b-598270e28615
relation.isAuthorOfPublication956d1326-eaa7-4251-a987-e010449a8c20
relation.isAuthorOfPublicationbb25b5ad-1769-42be-a7d3-8fe76215aa23
relation.isAuthorOfPublication.latestForDiscovery956d1326-eaa7-4251-a987-e010449a8c20
relation.isProjectOfPublication61f7a7ad-cc0a-49ae-99c6-f46b1341a1b6
relation.isProjectOfPublication2557b25b-958d-4bda-ae2e-df62f635d55a
relation.isProjectOfPublication.latestForDiscovery61f7a7ad-cc0a-49ae-99c6-f46b1341a1b6

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
antibiotics-14-00780.pdf
Size:
291.69 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
3.46 KB
Format:
Item-specific license agreed upon to submission
Description: